Cargando…
Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access
Cellular therapies and other regenerative medicines are emerging as potentially transformative additions to modern medicine, but likely at a staggering financial cost. Public health care systems’ budgets are already strained by growing and aging populations, and many private insurer's budgets a...
Autores principales: | Driscoll, Dawn, Farnia, Stephanie, Kefalas, Panos, Maziarz, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689744/ https://www.ncbi.nlm.nih.gov/pubmed/28749065 http://dx.doi.org/10.1002/sctm.16-0487 |
Ejemplares similares
-
Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015) -
Strategic planning decisions in the high tech industry
por: Cetindamar, Dilek, et al.
Publicado: (2013) -
Strategic Differentiation of High-Tech Services in Local Hospital Markets
por: Trinh, Hanh Q., et al.
Publicado: (2019) -
Planning and design for high-tech web-based training
por: Stone, David E, et al.
Publicado: (2002) -
How high-tech start-ups learn to cross the market chasm?
por: Goldasteh, Pouria, et al.
Publicado: (2022)